These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 7930631
1. Humanized antibody directed to the IL-2 receptor beta-chain prolongs primate cardiac allograft survival. Tinubu SA, Hakimi J, Kondas JA, Bailon P, Familletti PC, Spence C, Crittenden MD, Parenteau GL, Dirbas FM, Tsudo M. J Immunol; 1994 Nov 01; 153(9):4330-8. PubMed ID: 7930631 [Abstract] [Full Text] [Related]
2. Humanized Mik beta 1, a humanized antibody to the IL-2 receptor beta-chain that acts synergistically with humanized anti-TAC. Hakimi J, Ha VC, Lin P, Campbell E, Gately MK, Tsudo M, Payne PW, Waldmann TA, Grant AJ, Tsien WH. J Immunol; 1993 Jul 15; 151(2):1075-85. PubMed ID: 8335891 [Abstract] [Full Text] [Related]
3. Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survival. Brown PS, Parenteau GL, Dirbas FM, Garsia RJ, Goldman CK, Bukowski MA, Junghans RP, Queen C, Hakimi J, Benjamin WR. Proc Natl Acad Sci U S A; 1991 Apr 01; 88(7):2663-7. PubMed ID: 2011577 [Abstract] [Full Text] [Related]
4. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac. Hartmann F, Horak EM, Garmestani K, Wu C, Brechbiel MW, Kozak RW, Tso J, Kosteiny SA, Gansow OA, Nelson DL. Cancer Res; 1994 Aug 15; 54(16):4362-70. PubMed ID: 8044783 [Abstract] [Full Text] [Related]
5. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction. Phillips KE, Herring B, Wilson LA, Rickford MS, Zhang M, Goldman CK, Tso JY, Waldmann TA. Cancer Res; 2000 Dec 15; 60(24):6977-84. PubMed ID: 11156399 [Abstract] [Full Text] [Related]
6. Bispecific humanized anti-IL-2 receptor alpha beta antibodies inhibitory for both IL-2- and IL-15-mediated proliferation. Pilson RS, Levin W, Desai B, Reik LM, Lin P, Korkmaz-Duffy E, Campbell E, Tso JY, Kerwin JA, Hakimi J. J Immunol; 1997 Aug 01; 159(3):1543-56. PubMed ID: 9233654 [Abstract] [Full Text] [Related]
7. Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells. Tanaka K, Hancock WW, Osawa H, Stunkel KG, Alberghini TV, Diamantstein T, Tilney NL, Kupiec-Weglinski JW. J Immunol; 1989 Nov 01; 143(9):2873-9. PubMed ID: 2530281 [Abstract] [Full Text] [Related]
8. Systemic radioimmunotherapy using a monoclonal antibody, anti-Tac directed toward the alpha subunit of the IL-2 receptor armed with the alpha-emitting radionuclides (212)Bi or (211)At. Wesley JN, McGee EC, Garmestani K, Brechbiel MW, Yordanov AT, Wu C, Gansow OA, Eckelman WC, Bacher JD, Flynn M, Goldman CK, MacLin M, Schwartz UP, Jackson-White T, Phillip CM, Decker J, Waldmann TA. Nucl Med Biol; 2004 Apr 01; 31(3):357-64. PubMed ID: 15028248 [Abstract] [Full Text] [Related]
9. Anti-CD25 monoclonal antibody modulates cytokine expression and prolongs allografts survival in rats cardiac transplantation. Xia J, Jiang X, Huang Y, Zhang K, Xiao S, Yang C. Chin Med J (Engl); 2003 Mar 01; 116(3):432-5. PubMed ID: 12781053 [Abstract] [Full Text] [Related]
10. A novel monoclonal antibody against murine IL-2 receptor beta-chain. Characterization of receptor expression in normal lymphoid cells and EL-4 cells. Tanaka T, Tsudo M, Karasuyama H, Kitamura F, Kono T, Hatakeyama M, Taniguchi T, Miyasaka M. J Immunol; 1991 Oct 01; 147(7):2222-8. PubMed ID: 1918958 [Abstract] [Full Text] [Related]
11. Use of yttrium-90-labeled anti-Tac antibody in primate xenograft transplantation. Cooper MM, Robbins RC, Goldman CK, Mirzadeh S, Brechbiel MW, Stone CD, Gansow OA, Clark RE, Waldmann TA. Transplantation; 1990 Nov 01; 50(5):760-5. PubMed ID: 2238051 [Abstract] [Full Text] [Related]
12. Prolongation of murine cardiac allograft survival by the anti-interleukin-2 receptor monoclonal antibody AMT-13. Kirkman RL, Barrett LV, Koltun WA, Diamantstein T. Transplant Proc; 1987 Feb 01; 19(1 Pt 1):618-9. PubMed ID: 3274828 [No Abstract] [Full Text] [Related]
13. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy. Lietz K, John R, Beniaminovitz A, Burke EM, Suciu-Foca N, Mancini DM, Edwards NM, Itescu S. Transplantation; 2003 Mar 27; 75(6):781-7. PubMed ID: 12660501 [Abstract] [Full Text] [Related]
14. Humanized antibodies against the alpha-chain of the IL-2 receptor and against the beta-chain shared by the IL-2 and IL-15 receptors in a monkey uveitis model of autoimmune diseases. Guex-Crosier Y, Raber J, Chan CC, Kriete MS, Benichou J, Pilson RS, Kerwin JA, Waldmann TA, Hakimi J, Roberge FG. J Immunol; 1997 Jan 01; 158(1):452-8. PubMed ID: 8977222 [Abstract] [Full Text] [Related]
15. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model. Ito H, Hamano K, Fukumoto T, Wood KJ, Esato K. J Heart Lung Transplant; 1998 May 01; 17(5):460-9. PubMed ID: 9628564 [Abstract] [Full Text] [Related]
16. Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys. Bîrsan T, Hausen B, Higgins JP, Hubble RW, Klupp J, Stalder M, Celniker A, Friedrich S, O'Hara RM, Morris RE. Transplantation; 2003 Jun 27; 75(12):2106-13. PubMed ID: 12829920 [Abstract] [Full Text] [Related]
17. Reduced immunogenicity and improved pharmacokinetics of humanized anti-Tac in cynomolgus monkeys. Hakimi J, Chizzonite R, Luke DR, Familletti PC, Bailon P, Kondas JA, Pilson RS, Lin P, Weber DV, Spence C. J Immunol; 1991 Aug 15; 147(4):1352-9. PubMed ID: 1869828 [Abstract] [Full Text] [Related]
18. Intermediate- and high-affinity interleukin-2 receptors expressed in an IL-4-dependent T-cell line induce different signals. Rebollo A, Silva A. Immunology; 1993 Oct 15; 80(2):229-35. PubMed ID: 8262551 [Abstract] [Full Text] [Related]
19. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice. Cai Y, Tang XD, Zhou PJ. Scand J Immunol; 2005 Mar 15; 61(3):266-73. PubMed ID: 15787744 [Abstract] [Full Text] [Related]
20. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts. Wei RQ, Schwartz CF, Lin H, Chen GH, Bolling SF. J Surg Res; 1999 Feb 15; 81(2):123-8. PubMed ID: 9927530 [Abstract] [Full Text] [Related] Page: [Next] [New Search]